Sushrut S. Waikar, MD

Norman G. Levinsky Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Sushrut S. Waikar, MD, MPH received a BA in English and Neuroscience at Amherst College, his MD at Yale, and an MPH at Harvard. He is the Norman G. Levinsky Professor of Medicine at Chobanian and Avedisian School of Medicine and Chief of Nephrology at Boston Medical Center. Dr. Waikar's research interests and active projects include epidemiologic, translational, and interventional studies to address novel and clinically important questions in nephrology. Current areas of investigation include optimal diagnostic testing in acute kidney injury and chronic kidney disease; biomarkers of kidney pathology and kidney fibrosis; the identification of relevant targets for interventional trials in kidney disease; and randomized controlled trials. He is a Principal Investigator of several NIH grants including the Kidney Precision Medicine Project (U01 DK133092), Multi-omics and Chronic Kidney Disease: Correlation with Histology (R01 DK108803), Discovery Science Collaborative for CKDu (U01 DK130060), NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial (U01AG076789) andThe Boston University Kidney and Medical Engineering Program (BU-KIDMEP, R25 DK128858).

Publications

  • Published 7/29/2026

    Tsai MT, Li SY, Kim D, Park J, Schmidt IM, Zhao R, Waikar SS, Hsieh TH, Yang H, Chen TH, Ou SM, Yang RB. Galectin-9 as a circulating marker of mesangial injury and prognosis in biopsy-proven kidney disease. Am J Nephrol. 2026 Jul 29; 1-24. PMID: 42525588.

    Read at: PubMed

  • Published 7/27/2026

    Moritz ML, Ciapponi A, Hsu CY, Nigwekar SU, Singhal AB, Rhee CM, Kalantar-Zadeh K, Waikar S, Kovesdy CP, Ayus JC. Hyponatremia treatment guidelines: a necessary course correction. Kidney Int. 2026 Jul 27. PMID: 42535992.

    Read at: PubMed

  • Published 7/17/2026

    Parisien-La Salle S, Tsai CH, Newman AJ, Heydarpour M, Mahrokhian S, Hanna I, Brown JM, Waikar S, Moussa M, Vaidya A. Reprogramming of Iron and Oxygen Metabolism Across the Spectrum of Primary Aldosteronism. medRxiv. 2026 Jul 17. PMID: 42326790.

    Read at: PubMed

  • Published 6/17/2026

    Chrysopoulou M, de la Rosa X, Tan Y, Kovalenko E, Hahn O, Andersen JF, Lassé M, Matchkov V, Wulfmeyer VC, Jaegers J, Billing AM, Colby E, Bleich M, Schermer B, Kostidis S, Giera M, Peti-Peterdi J, Rhee EP, Grams ME, Waikar SS, Waldman M, Tomas NM, Saleem MA, Himmerkus N, Schmidt IM, Berg P, Demir F, Rinschen MM. Diversion of Arginine's dietary metabolic fate in proteinuric kidney disease. Res Sq. 2026 Jun 17. PMID: 42370251.

    Read at: PubMed

  • Published 6/4/2026

    Rosan SH, Verma A, Claudel SE, Srivastava A, Palsson R, Stillman IE, Henderson J, Waikar SS, Schmidt IM. Associations of serum uric acid levels with podocyte injury and kidney histopathologic lesions. J Nephrol. 2026 Jun 04; 39(1):215-217. PMID: 41921046.

    Read at: PubMed

View All 367 Publications:   View Full Profile in BUMC

Other Positions

  • Section Chief, Medicine
    Boston University Chobanian & Avedisian School of Medicine

Websites

Education

  • Yale University, MD
  • Harvard School of Public Health, MPH
  • Amherst College, BA

View all profiles